Publications

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model

 50
Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model

Tags:

Previous Article

How muscle cells grow and stay healthy

Next Article

MicroRNA-based gene therapy to treat ALS 

Related Posts

Sugar symphony: glycosylation in cancer metabolism and stemness

Sugar symphony: glycosylation in cancer metabolism and ...

 123

Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

Targeted degradation of oncogenic KRAS G12V triggers ...

 110

Structural basis of DNA-dependent coactivator recruitment by the tuft cell master regulator POU2F3

Structural basis of DNA-dependent coactivator recruitme...

 46